User login
Poll
Popular content
Today's:
- Hitachi Consulting UK Enables London’s Primary Care Trusts to Monitor and Benchmark Performance via Online Portal Platform
- Elsevier Announces 2008 Journal Impact Factor Highlights
- VereFlu™ - Detects and Identifies Human Influenza A and B and its subtypes in a Single Test
- MONEY WORRIES LEADING TO STRESS ACCORDING TO NEW RESEARCH
- New Wheelchair Light Launched
All time:
- List of medical apps for iPhone 3g and iTouch
- Priory Warns of Effects Of Unemployment on Mental Health
- VereFlu™ - Detects and Identifies Human Influenza A and B and its subtypes in a Single Test
- Demand for Private Swine Flu Tests as Government Stops Testing
- GSK's Cervical Cancer Vaccines research study published in The Lancet
HIV Vaccine
September 24, 2009 by srrpenna
The combination of two vaccines that has previously failed to produce a response on their own has cut the risk of becoming infected with HIV by more than 31 per cent.
It is the first time in human trials that a vaccine has protected against the virus which leads to Aids.
The vaccines are ALVAC, from Sanofi Pasteur, the vaccine division of French drugmaker Sanofi-Aventis; and AIDSVAX, originally developed by VaxGen Inc. and now held by Global Solutions for Infectious Diseases, a non-profit founded by some former VaxGen employees.
All the participants tested negative at the start of the trial and were given condoms, counselling and treatment for any sexually transmitted infections. They were tested every six months for HIV and any who became infected were given free treatment with antiviral medicines.
Read more from Telegraph
Permalink
- srrpenna's blog
- Login or register to post comments
Medical News - Recent blog posts
- MONEY WORRIES LEADING TO STRESS ACCORDING TO NEW RESEARCH
- Priory Group Leads on Expert Forensic Mental Health Conference
- Stoke Care Home Welcomes Dignity Day
- Priory warns of dangers of work-related stress
- Cool-Tel online vaccine monitoring system provides protection which surpasses new NHS advice.
- Hitachi Consulting UK Enables London’s Primary Care Trusts to Monitor and Benchmark Performance via Online Portal Platform
- Ben Receives Top Prize in Priory Essay Competition
- Priory makes major investment in Roehampton hospital
- Priory Group opens first care home in Yorkshire
- Advice for Depression Sufferers at Christmas
New forum topics
- Catching up on lost sleep a dangerous illusion
- Stress could be a trigger for some cancers, new research suggests
- Stem cell treatment for HIV and AIDS treatment
- U.S. Cancer Rates Continue Their Decline: Report
- Smokers who enjoy cigarette first thing more likely to get lung cancer
- Obese children taken off at-risk register after genes found to be at fault
- Ancient HIV Stowaway May Hold Clue to Transmission
- No cancer risk from increased mobile phone use
- Protein balance helps longevity
- Patients are at risk of clots for up to one year following surgery
Active forum topics
Tags in Speciality
Anatomy
Basic Sciences
Biochemistry
Cardiology
Ear Nose and Throat
General Medicine
General Practice
General Surgery
Infectious Diseases
Medicine
Microbiology
Obstetrics and Gynaecology
Oncology
Paediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Radiology
Respiratory Medicine
Surgery
Trauma And Orthopaedics
Urology